RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,620,000 | +83620.9% | 1,500,000 | 0.0% | 1.72% | -8.9% |
| Q2 2023 | $1,935 | -2.3% | 1,500,000 | 0.0% | 1.89% | -19.7% |
| Q1 2023 | $1,980 | -12.0% | 1,500,000 | 0.0% | 2.35% | -12.5% |
| Q4 2022 | $2,250 | -99.9% | 1,500,000 | +15.4% | 2.69% | +57.0% |
| Q3 2022 | $1,534,000 | +4.4% | 1,300,000 | 0.0% | 1.71% | +9.5% |
| Q2 2022 | $1,469,000 | -36.6% | 1,300,000 | +67.7% | 1.56% | -19.6% |
| Q1 2022 | $2,317,000 | +12.8% | 775,000 | 0.0% | 1.94% | +25.3% |
| Q4 2021 | $2,054,000 | -24.6% | 775,000 | +3.3% | 1.55% | -23.6% |
| Q3 2021 | $2,723,000 | -16.3% | 750,000 | 0.0% | 2.03% | -13.6% |
| Q2 2021 | $3,255,000 | +90.4% | 750,000 | +50.0% | 2.35% | +85.1% |
| Q1 2021 | $1,710,000 | +22.1% | 500,000 | +25.0% | 1.27% | -2.1% |
| Q4 2020 | $1,400,000 | – | 400,000 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,847,087 | $4,119,000 | 3.26% |
| Sio Capital Management, LLC | 1,333,696 | $2,974,000 | 1.52% |
| Boxer Capital, LLC | 700,000 | $1,561,000 | 1.38% |
| Palo Alto Investors LP | 5,386,534 | $12,012,000 | 0.91% |
| ACUTA CAPITAL PARTNERS, LLC | 747,748 | $1,667,000 | 0.80% |
| SENZAR ASSET MANAGEMENT, LLC | 1,443,003 | $3,217,897,000 | 0.70% |
| Ghost Tree Capital, LLC | 800,000 | $1,784,000 | 0.52% |
| NEA Management Company, LLC | 3,243,150 | $7,232,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 850,000 | $1,896,000 | 0.34% |
| Rock Springs Capital Management LP | 1,750,000 | $3,903,000 | 0.29% |